Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Comparative skin dose measurement in the treatment of anal canal cancer: Conventional versus conformal therapy
1.B. Cummings, T. Keane, G. Thomas, A. Harwood, and W. Rider, “Results and toxicity of the treatment of anal carcinoma by radiation therapy or radiation therapy and chemotherapy,” Can. Mineral. 54, 2062–2068 (1984).
2.N. Nigro, “The force of change in the management of squamous cell cancer of the anal canal,” Dis. Colon Rectum 34, 482–486 (1991).
3.M. John, T. Pajak, M. Flam, J. Hoffman, A. Markoe, H. Wolkov, and K. Paris, “Dose escalation in chemoradiotherapy for anal cancer: preliminary results of RTOG 92-08,” Cancer J. Sci. Am. 2, 205–211 (1996).
4.M. John, T. Pajak, R. Kreig, W. H. Pinover, and R. Myerson, “Dose escalation without split course chemo radiation for anal canal cancer: results of a phase II RTOG study. Proceedings of the 39th annual ASTRO meeting,” Int. J. Radiat. Oncol., Biol., Phys. 39, 203 (1997).
5.M. Flam, M. John, T. Pajak, N. Petrelli, R. Myerson, S. Doggett, J. Quivey, M. Rotman, H. Kerman, L. Coia, and K. Murray, “Role of mitomycin in combination with fluorouracil and radiotherapy, and salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anus: results of a phase III randomized study,” J. Clin. Oncol. 14, 2527–2539 (1996).
6.H. Bartelink, F. Roelofsen, F. Eschwege, P. Rougier, J. F. Bosset, D. G. Gonzalez, D. Peiffert, M. van Glabbeke, and M. Pierart, “Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative groups,” J. Clin. Oncol. 15, 2040–2049 (1997).
7.UKCCCR Anal Cancer Trial Working Party, “Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5 Fluorouracil, and Mitomycin,” Lancet 348, 1049–1054 (1996).
8.T. Vuong, S. Devic, P. Belliveau, T. Muanza, and G. Hegyi, “Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiation treatment: Results of a phase II study,” Int. J. Radiat. Oncol., Biol., Phys. 56, 823–831 (2003).
9.C. L. Hartmann Siantar, R. S. Walling, T. P. Daly, B. Faddegon, N. Albright, P. Bergstrom, A. F. Bielajew, C. Chuang, D. Garrett, R. K. House, D. Knapp, D. J. Wieczorek, and L. J. Verhey, “Description and dosimetric verification of the PEREGRINE Monte Carlo dose calculation system for photon beams incident on a water phantom,” Med. Phys. 28, 1322–1337 (2001).
10.G. X. Ding, “Energy spectra, angular spread, fluence profiles and dose distributions of 6 and 18 MV photon beams: results of Monte Carlo simulations for a Varian 2100-EX accelerator,” Phys. Med. Biol. 47, 1025–1046 (2002).
11.G. X. Ding, “Dose discrepancies between Monte Carlo calculations and measurements in the buildup region for a high-energy photon beam,” Med. Phys. 29, 2459–2463 (2002).
12.B. Nilsson and B. Sorcini, “Surface dose measurements in clinical photon beams,” Acta Oncol. 28, 537–542 (1989).
13.P. Francescon, S. Cora, C. Cavedon, P. Scalchi, S. Reccanello, and F. Colombo, “Use of a new type of radiochromic film, a new parallel-plate micro-chamber, MOSFETs, and TLD 800 microcubes in the dosimetry of small beams,” Med. Phys. 25, 503–511 (1998).
14.B. Fraass and J. van de Giejn, “Peripheral dose from megavolt beams,” Med. Phys. 10, 809–818 (1983).
15.K. Kase, G. Svensson, A. Wolbarst, and M. Marks, “Measurement of dose from secondary radiation outside a treatment field,” Int. J. Radiat. Oncol., Biol., Phys. 9, 1177–1183 (1983).
16.D. Mellenberg, “Dose behind various immobilization and beam modifying devices,” Int. J. Radiat. Oncol., Biol., Phys. 32, 1193–1197 (1995).
17.T. Kron, A. Elliott, T. Wong, G. Showell, B. Clubb, and P. Metcalfe, “X-ray surface dose measurements using TLD extrapolation,” Med. Phys. 20, 703–711 (1993).
18.M. J. Butson, P. K. N. Yu, and P. E. Metcalfe, “Measurement of off-axis and peripheral skin dose using radiochromic film,” Phys. Med. Biol. 43, 2647–2650 (1998).
19.K. Y. Quach, J. Morales, M. J. Butson, A. B. Rosenfeld, and P. E. Metcalfe, “Measurement of radiotherapy x-ray skin dose on a chest wall phantom,” Med. Phys. 27, 1676–1680 (2000).
20.T. Cheung, M. J. Butson, and P. K. N. Yu, “Multilayer GafChromic film detectors for breast skin dose determination in vivo,” Phys. Med. Biol. 47, N31–N37 (2002).
21.M. J. Butson, J. N. Mathur, and P. E. Metcalfe, “Radiochromic film as a radiotherapy surface–dose detector,” Phys. Med. Biol. 41, 1073–1078 (1996).
22.M. J. Butson, P. K. N. Yu, and P. E. Metcalfe, “Extrapolated surface dose measurements with radiochromic film,” Med. Phys. 26, 485–488 (1999).
23.E. Giles and P. Murphy, “Measuring skin dose with radiochromic dosimetry film in the cardiac laboratory,” Health Phys. 82, 875–880 (2002).
24.M. J. Butson, K. N. Yu, T. Cheung, and P. E. Metcalfe, “Radiochromic film for Medical Radiation Dosimetry,” Mater. Sci. Eng., R. 41, 61–120 (2003).
25.A. Niroomand-Rad, C. R. Blackwell, B. M. Coursey, K. P. Gall, J. M. Galvin, W. L. McLaughlin, A. S. Meigooni, R. Nath, J. E. Rodgers, and C. G. Soares, “Radiochromic film dosimetry: Recommendations of AAPM Radiation Therapy Committee Task Group 55,” Med. Phys. 25, 2093–2115 (1998).
26.M. J. Butson, P. K. N. Yu, and P. E. Metcalfe, “Effects of read-out light sources and ambient light on radiochromic film,” Phys. Med. Biol. 43, 2407–2412 (1998).
27.P. R. Almond, P. J. Biggs, B. M. Coursey, W. F. Hanson, M. Saiful Huq, R. Nath, and D. W. O. Rogers, “AAPM’s TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams,” Med. Phys. 26, 1847–1870 (1999).
Article metrics loading...